RPG Life Sciences Ltd Financials
Company Logo

RPG Life Sciences Ltd Financial Statement

RPG Life Sciences Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
Revenue174.15
Operating Expense153.58
Net Profit4.20
Net Profit Margin2.41
Earning Per Share2.54
EBIDTA20.46
Effective Tax Rate52.41
Invest in RPG Life Sciences Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

RPG Life Sciences Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual582.05
Operating Expenses Annual453.90
Operating Profit Annual135.36
Interest Annual0.45
Depreciation10.41
Net Profit Annual87.66
Tax Annual30.18

RPG Life Sciences Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning24.82
Cash Flow from Operations94.36
Cash Flow from Investing-79.15
Cash Flow from Financing-20.31
Cash Flow at the End19.72

RPG Life Sciences Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)23.43
PBIT Margin (%)20.49
PBT Margin (%)6.26
Net PROFIT Margin (%)15.06
Return On Networth / Equity (%)25.69
Return On Networth /Employed (%)34.25
Return On Assets (%)25.15
Total Debt / Equity (X)TBA
Asset Turnover Ratio (%)1.67

RPG Life Sciences Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual125.06
Total Current Assets Annual298.09
Non Current Assets Annual214.78
Total Shareholders Funds Annual374.85
Total Assets Annual512.87

RPG Life Sciences Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Nov 23, 2024, RPG Life Sciences Ltd has a market capitalization of 2,530.80 Cr. Value Research classifies it as a Mid-Cap company.
Yes, RPG Life Sciences Ltd is debt-free with a debt-to-equity ratio of 0.00.
In FY 2023 , RPG Life Sciences Ltd recorded a total revenue of approximately 582.05 Cr marking a significant milestone in the company's financial performance.
RPG Life Sciences Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.5% and 0.1% annually, respectively..
RPG Life Sciences Ltd's current PE ratio is 28.87.
RPG Life Sciences Ltd's ROCE averaged 29.8% from the FY ending March 2022 to 2024, with a median of 29.6%. It peaked at 31.3% in March 2024, reflecting strong capital efficiency over the period..
RPG Life Sciences Ltd's latest EBIT is Rs. 118.29 Cr, surpassing the average EBIT of Rs. 94.66 Cr over the 5 years..